Dedifferentiation of neuroendocrine carcinoma of the uterine cervix in hypoxia.
Kubota S, Tanaka M, Endo H, Ito Y, Onuma K, Ueda Y, Kamiura S, Yoshino K, Kimura T, Kondo J, Inoue M.
Biochem Biophys Res Commun. 2020 Apr 2;524(2):398-404. doi: 10.1016/j.bbrc.2020.01.024. Epub 2020 Jan 30.
PMID:32007268
SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix.
Inzani F, Angelico G, Santoro A, Travaglino A, Insabato L, Raffone A, Arciuolo D, Scaglione G, D'Alessandris N, Valente M, Carlino A, Rindi G, Zannoni GF.
Virchows Arch. 2022 Apr;480(4):873-877. doi: 10.1007/s00428-021-03255-7. Epub 2022 Jan 29.
PMID:35091815
Multimodal treatment for resectable neuroendocrine carcinoma of the cervix.
Valenza C, Spada F, Multinu F, Benini L, Borghesani M, Algeri L, Rubino M, Pisa E, Gervaso L, Cella CA, Carinelli S, Bruni S, Schivardi G, Curigliano G, Zanagnolo V, Aletti G, Colombo N, Fazio N.
Endocr Relat Cancer. 2023 Aug 14;30(10):e230112. doi: 10.1530/ERC-23-0112. Print 2023 Oct 1.